MENU
+Compare
DBD
Stock ticker: NYSE
AS OF
Apr 23 closing price
Price
$42.54
Change
+$0.75 (+1.79%)
Capitalization
1.29B

DBD Diebold Nixdorf Forecast, Technical & Fundamental Analysis

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries... Show more

DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DBD with price predictions
Apr 22, 2025

DBD's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for DBD moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 6 similar instances when the indicator left oversold territory. In of the 6 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on DBD as a result. In of 29 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DBD just turned positive on April 15, 2025. Looking at past instances where DBD's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in of 107 cases, the price rose further within the following month. The odds of a continued upward trend are .

DBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

DBD moved below its 50-day moving average on April 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DBD entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.209) is normal, around the industry mean (30.787). P/E Ratio (0.000) is within average values for comparable stocks, (160.020). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.707). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (0.749) is also within normal values, averaging (59.678).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DBD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DBD is expected to report earnings to fall 39.18% to 58 cents per share on May 13

Diebold Nixdorf DBD Stock Earnings Reports
Q1'25
Est.
$0.59
Q4'24
Missed
by $0.47
Q3'24
Missed
by $0.51
Q2'24
Beat
by $0.14
Q1'24
Beat
by $0.42
The last earnings report on February 12 showed earnings per share of 97 cents, missing the estimate of $1.44. With 191.58K shares outstanding, the current market capitalization sits at 1.29B.
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
350 Orchard Avenue NE
Phone
+1 330 490-4000
Employees
21000
Web
https://www.dieboldnixdorf.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCDVX17.240.34
+2.01%
BlackRock Equity Dividend Inv C
LGIEX18.78N/A
N/A
Franklin International Equity I
ARYDX12.51N/A
N/A
American Century Global Real Estate R6
PCMSX14.17N/A
N/A
Principal MidCap Value I R6
MIEDX8.47N/A
N/A
MassMutual International Eq R5

DBD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DBD has been loosely correlated with PLUS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then PLUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBD
1D Price
Change %
DBD100%
+2.93%
PLUS - DBD
44%
Loosely correlated
+2.59%
NATL - DBD
44%
Loosely correlated
+5.16%
GDRX - DBD
43%
Loosely correlated
+1.83%
DJCO - DBD
42%
Loosely correlated
+2.62%
EGHT - DBD
42%
Loosely correlated
-0.61%
More